Literature DB >> 21453184

Molecular epidemiological analysis of env and pol sequences in newly diagnosed HIV type 1-infected, untreated patients in Hungary.

Mária Mezei1, Eva Ay, Anita Koroknai, Renáta Tóth, Andrea Balázs, Agnes Bakos, Zoltán Gyori, Ferenc Bánáti, Márta Marschalkó, Sarolta Kárpáti, János Minárovits.   

Abstract

The aim of our study was to monitor the diversity of HIV-1 strains circulating in Hungary and investigate the prevalence of resistance-associated mutations to reverse transcriptase (RT) and protease (PR) inhibitors in newly diagnosed, drug-naive patients. A total of 30 HIV-1-infected patients without prior antiretroviral treatment diagnosed during the period 2008-2010 were included into this study. Viral subtypes and the presence of RT, PR resistance-associated mutations were established by sequencing. Classification of HIV-1 strains showed that 29 (96.6%) patients were infected with subtype B viruses and one patient (3.3%) with subtype A virus. The prevalence of HIV-1 strains with transmitted drug resistance mutations in newly diagnosed individuals was 16.6% (5/30). This study showed that HIV-1 subtype B is still highly predominant in Hungary and documented a relatively high transmission rate of drug resistance in our country.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21453184     DOI: 10.1089/aid.2011.0077

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  6 in total

1.  Ten years survey of primary HIV-1 resistance in Serbia: the occurrence of multiclass resistance.

Authors:  Maja Stanojevic; Marina Siljic; Dubravka Salemovic; Ivana Pesic-Pavlovic; Sonja Zerjav; Valentina Nikolic; Jovan Ranin; Djordje Jevtovic
Journal:  AIDS Res Hum Retroviruses       Date:  2014-04-09       Impact factor: 2.205

2.  The prevalence of transmitted drug resistance in newly diagnosed HIV-infected individuals in Croatia: the role of transmission clusters of men who have sex with men carrying the T215S surveillance drug resistance mutation.

Authors:  Ivana Grgic; Snjezana Zidovec Lepej; Maja M Lunar; Mario Poljak; Adriana Vince; Ivana Baca Vrakela; Ana Planinic; Katja Seme; Josip Begovac
Journal:  AIDS Res Hum Retroviruses       Date:  2012-10-04       Impact factor: 2.205

3.  Short communication: prevalence of HIV type 1 transmitted drug resistance in Slovenia: 2005-2010.

Authors:  Maja M Lunar; Snježana Židovec Lepej; Ana B Abecasis; Janez Tomažič; Ludvik Vidmar; Primož Karner; Tomaž D Vovko; Blaž Pečavar; Polona J Maver; Katja Seme; Mario Poljak
Journal:  AIDS Res Hum Retroviruses       Date:  2012-08-29       Impact factor: 2.205

Review 4.  Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia.

Authors:  Georgios K Nikolopoulos; Evangelia-Georgia Kostaki; Dimitrios Paraskevis
Journal:  Infect Genet Evol       Date:  2016-06-07       Impact factor: 3.342

5.  HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update.

Authors:  Maja M Lunar; Snježana Židovec Lepej; Janez Tomažič; Tomaž D Vovko; Blaž Pečavar; Gabriele Turel; Manja Maver; Mario Poljak
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

6.  Analysis of HIV-1 diversity, primary drug resistance and transmission networks in Croatia.

Authors:  Maja Oroz; Josip Begovac; Ana Planinić; Filip Rokić; Maja M Lunar; Tomaž Mark Zorec; Robert Beluzić; Petra Korać; Oliver Vugrek; Mario Poljak; Snježana Židovec Lepej
Journal:  Sci Rep       Date:  2019-11-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.